Skip to content

Comparison of Chlorpromazine or Pentobarbital Premedications for Pediatric Imaging Procedures

Comparison of Sedation Using Pentobarbital or Chlorpromazine in Pediatric Non-invasive Imaging Procedure: A Before and After Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04350528
Acronym
PREIMAPED
Enrollment
254
Registered
2020-04-17
Start date
2020-04-30
Completion date
2020-06-30
Last updated
2020-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children Sedation

Keywords

Sedation, Medical imaging, Children, Pentobarbital, Chlorpromazine, Efficacy, Safety

Brief summary

Sedation is often required for pediatric medical imaging procedures to ensure compliance and quality images. Recommendations exist regarding pediatric sedation, but there are currently no guidelines regarding the choice of the sedative drug. We aim to compare the efficacy and adverse events of per os pentobarbital with intravenous chlorpromazine in children undergoing diagnostic imaging procedures.

Interventions

DRUGChlorpromazine or Pentobarbital

Sedation

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children * Sedation for the purpose of imaging * Sedation using chlorpromazine or pentobarbital

Exclusion criteria

* Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Sedation successDuring the procedureImaging purpose is answered

Secondary

MeasureTime frameDescription
Hospitalization durationThrough procedure completionLength of time from planned time of admission to discharge
Duration of the imaging procedureDuring the procedureLength of acquisition time from the first to the last images
Secondary effectsFrom Procedure until 2 days afterNumber of participant developing any secondary effects
Induction timeDuring the procedureLength of time required after the administration to achieve adequate sedation
Failure of pentobarbital sedation in children with a behavioral disorderDuring the procedureComparison of the rate of failure of pentobarbital sedation in children with a behavioral disorder compared to those without
Failure of pentobarbital sedation in children under chronic antiepileptic treatmentDuring the procedureComparison of the rate of failure of pentobarbital sedation in children under chronic antiepileptic treatment compared to those without
Failure of pentobarbital sedation in children older than 5 yearsDuring the procedureComparison of the rate of failure of pentobarbital sedation in children older than 5 years compared to those younger.

Countries

France

Contacts

Primary ContactJuliette ROPARS, MD
juliette.ropars@chu-brest.fr02 98 22 33 89

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026